Goldman Sachs’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.6M | Sell |
|
|||||
|
2025
Q2 | $60.2M | Sell |
|
|||||
|
2025
Q1 | $50.5M | Sell |
|
|||||
|
2024
Q4 | $90.7M | Buy |
|
|||||
|
2024
Q3 | $75.4M | Buy |
|
|||||
|
2024
Q2 | $55M | Buy |
|
|||||
|
2024
Q1 | $7.94M | Buy |
|
|||||
|
2023
Q4 | $9.13M | Buy |
|
|||||
|
2023
Q3 | $5.51M | Buy |
|
|||||
|
2023
Q2 | $4.56M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $106K | Sell |
|
|||||
|
2022
Q3 | $79K | Sell |
|
|||||
|
2022
Q2 | $62K | Buy |
|